Obamacare’s fate may rest on patience of Anthem, Aetna
Anthem Inc. and Aetna Inc. are on the hot seat now that UnitedHealth Group Inc. appears unlikely to linger as a seller on the Affordable Care Act’s government-run markets.
Anthem Inc. and Aetna Inc. are on the hot seat now that UnitedHealth Group Inc. appears unlikely to linger as a seller on the Affordable Care Act’s government-run markets.
Insurer UnitedHealth Group, which has 28,000 Obamacare customers in Indiana, said it might quit selling plans under the Affordable Care Act. Thursday’s announcement took a toll on health insurance stocks, including Anthem’s.
Assistant Attorney General William Baer said that consumer choice is a bigger priority than health companies’ desire to add market share and gain leverage over providers like hospitals.
Anthem Inc. shouldn’t be permitted to buy Cigna Corp. and Aetna Inc. should be blocked from acquiring Humana Inc., the American Medical Association said in a letter Wednesday to the head of the Justice Department’s antitrust division.
Slipping enrollment has done little to shake the faith that the nation's biggest health insurers, including Anthem, have placed in the Affordable Care Act's public insurance exchanges.
Anthem’s third-quarter profit rose nearly 4 percent as it added 174,000 health plan members. Its Medicaid, local employer and national employer segments all grew, although its individual business saw losses.
Shares in Anthem Inc. and Cigna Corp., which agreed to a $48 billion deal in July, continued to slide Thursday after presidential candidate Hillary Clinton said mergers in the industry deserve more scrutiny.
Presidential candidate Hillary Rodham Clinton warned Wednesday that the planned $48B deal could stifle competition between health insurers, including in the early battleground state of New Hampshire.
Anthem Inc. CEO Joseph Swedish and Aetna Inc. CEO Mark Bertolini will tell federal lawmakers Tuesday that the deals are necessary to succeed in a changing health-care landscape.
Four of the 10 metro areas that will see the biggest decrease in competition from the Anthem-Cigna merger are in Indiana, according to an analysis by the American Medical Association—with Indianapolis facing the second-biggest impact among all of Anthem’s markets nationwide.
The market for health-insurance in the U.S. is already so highly concentrated that pending tie-ups among four of the country’s largest insurers risk hurting both consumers and doctors, the American Medical Association said.
Concerns about serious side effects, including fainting, complicate discussions about whether to cover Sprout Pharmaceuticals' Addyi.
Anthem Inc. has used the Blue Cross and Blue Shield brand names as a powerful tool on its way to becoming the nation’s second-largest health insurer. But those Blue brands now are a hurdle for Anthem’s $54.2 billion acquisition of Cigna Corp.
Mega-mergers among Anthem Inc. and its fellow health insurance giants could put pressure on provider-owned health plans such as Advantage Health Solutions and Indiana University Health Plans.
Indianapolis-based Anthem Inc. reported Wednesday morning that it earned $859.1 million during the three months ended June 30, an increase of 17.5 percent over the same quarter of 2014.
Anthem Inc.’s bid to become the largest health insurer in history is setting up one of the biggest debt offerings backing a takeover.
Seeing mergers like Anthem’s planned acquisition of Cigna Corp., hospitals could decide that striking deals of their own could improve their negotiating power over medical reimbursements.
The company says its corporate headquarters will remain in Indianapolis, where its operations are responsible for contributing millions of dollars in corporate taxes and charitable giving.
This 1992 profile of then-CEO L. Ben Lytle chronicles the evolution of the company—then known as The Associated Group—from a sleepy health insurer operating in only one state into an acquisitive, aggressive business with national ambitions.
After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.